Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China

PURPOSE: Dipeptidylpeptidase-4 (DPP-4) inhibitors, including linagliptin, alogliptin, saxagliptin, sitagliptin, and vildagliptin, are used for the treatment of type 2 diabetes mellitus (T2DM) patients in China. This study assessed the economic outcomes of different DPP-4 inhibitors in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wen-Qiang, Cai, Zhong-jie, Chen, Tingting, Liu, Mao-Bai, Li, Na, Zheng, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415028/
https://www.ncbi.nlm.nih.gov/pubmed/34484112
http://dx.doi.org/10.3389/fendo.2021.684960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415028/
https://www.ncbi.nlm.nih.gov/pubmed/34484112
http://dx.doi.org/10.3389/fendo.2021.684960

Ejemplares similares